163 related articles for article (PubMed ID: 24959214)
1. Genetic alterations of chromosomes, p53 and p16 genes in low- and high-grade bladder cancer.
Abat D; Demirhan O; Inandiklioglu N; Tunc E; Erdogan S; Tastemir D; Uslu IN; Tansug Z
Oncol Lett; 2014 Jul; 8(1):25-32. PubMed ID: 24959214
[TBL] [Abstract][Full Text] [Related]
2. Alterations in p16 and p53 genes and chromosomal findings in patients with lung cancer: fluorescence in situ hybridization and cytogenetic studies.
Demirhan O; Taştemir D; Hastürk S; Kuleci S; Hanta I
Cancer Epidemiol; 2010 Aug; 34(4):472-7. PubMed ID: 20444664
[TBL] [Abstract][Full Text] [Related]
3. Genetic and molecular markers of urothelial premalignancy and malignancy.
Cordon-Cardo C; Cote RJ; Sauter G
Scand J Urol Nephrol Suppl; 2000; (205):82-93. PubMed ID: 11144907
[TBL] [Abstract][Full Text] [Related]
4. Noninvasive detection of alterations in chromosome numbers in urinary bladder cancer cells, using fluorescence in situ hybridization.
Okamura T; Umemoto Y; Yasui T; Saiki S; Kuroda H; Kotoh S; Kamizaki H
Int J Clin Oncol; 2004 Oct; 9(5):373-7. PubMed ID: 15549587
[TBL] [Abstract][Full Text] [Related]
5. Deletion of the p16 and p15 genes in human bladder tumors.
Orlow I; Lacombe L; Hannon GJ; Serrano M; Pellicer I; Dalbagni G; Reuter VE; Zhang ZF; Beach D; Cordon-Cardo C
J Natl Cancer Inst; 1995 Oct; 87(20):1524-9. PubMed ID: 7563186
[TBL] [Abstract][Full Text] [Related]
6. Chromosomal imbalances in successive moments of human bladder urothelial carcinoma.
Nascimento e Pontes MG; da Silveira SM; Trindade Filho JC; Rogatto SR; Viana de Camargo JL
Urol Oncol; 2013 Aug; 31(6):827-35. PubMed ID: 21763161
[TBL] [Abstract][Full Text] [Related]
7. Alterations of the 9p21 and 9q33 chromosomal bands in clinical bladder cancer specimens by fluorescence in situ hybridization.
Stadler WM; Steinberg G; Yang X; Hagos F; Turner C; Olopade OI
Clin Cancer Res; 2001 Jun; 7(6):1676-82. PubMed ID: 11410506
[TBL] [Abstract][Full Text] [Related]
8. p53, p21, pRB, and p16 expression predict clinical outcome in cystectomy with bladder cancer.
Shariat SF; Tokunaga H; Zhou J; Kim J; Ayala GE; Benedict WF; Lerner SP
J Clin Oncol; 2004 Mar; 22(6):1014-24. PubMed ID: 14981102
[TBL] [Abstract][Full Text] [Related]
9. Chromosomal imbalances in human bladder urothelial carcinoma: similarities and differences between biopsy samples and cancer stem-like cells.
Conconi D; Panzeri E; Redaelli S; Bovo G; Viganò P; Strada G; Dalprà L; Bentivegna A
BMC Cancer; 2014 Sep; 14():646. PubMed ID: 25178926
[TBL] [Abstract][Full Text] [Related]
10. [Molecular genetics of urinary bladder cancer progression].
Sauter G; Simon R; Bubendorf L; Mihatsch M
Verh Dtsch Ges Pathol; 2002; 86():49-56. PubMed ID: 12647351
[TBL] [Abstract][Full Text] [Related]
11. Sex chromosome abnormalities in bladder cancer: Y polysomies are linked to PT1-grade III transitional cell carcinoma.
Panani AD; Roussos C
Anticancer Res; 2006; 26(1A):319-23. PubMed ID: 16475713
[TBL] [Abstract][Full Text] [Related]
12. The prevalence and clinicopathologic correlate of p16INK4a, retinoblastoma and p53 immunoreactivity in locally advanced urinary bladder cancer.
Tzai TS; Tsai YS; Chow NH
Urol Oncol; 2004; 22(2):112-8. PubMed ID: 15082007
[TBL] [Abstract][Full Text] [Related]
13. Epigenome-Wide DNA Methylation Profiling Identifies Differential Methylation Biomarkers in High-Grade Bladder Cancer.
Olkhov-Mitsel E; Savio AJ; Kron KJ; Pethe VV; Hermanns T; Fleshner NE; van Rhijn BW; van der Kwast TH; Zlotta AR; Bapat B
Transl Oncol; 2017 Apr; 10(2):168-177. PubMed ID: 28167242
[TBL] [Abstract][Full Text] [Related]
14. Status of the p53, p16, RB1, and HER-2 genes and chromosomes 3, 7, 9, and 17 in advanced bladder cancer: correlation with adjacent mucosa and pathological parameters.
Gallucci M; Guadagni F; Marzano R; Leonardo C; Merola R; Sentinelli S; Ruggeri EM; Cantiani R; Sperduti I; Lopez Fde L; Cianciulli AM
J Clin Pathol; 2005 Apr; 58(4):367-71. PubMed ID: 15790699
[TBL] [Abstract][Full Text] [Related]
15. Using Grade of Recurrent Tumor to Guide Further Therapy While on Bacillus Calmette-Guerin: Low-grade Recurrences Are not Benign.
Li R; Metcalfe MJ; Tabayoyong WB; Guo CC; Nogueras González GM; Navai N; Grossman HB; Dinney CP; Kamat AM
Eur Urol Oncol; 2019 May; 2(3):286-293. PubMed ID: 31200843
[TBL] [Abstract][Full Text] [Related]
16. Sjögren's syndrome and MALT lymphomas of salivary glands: a DNA-cytometric and interphase-cytogenetic study.
Ihrler S; Baretton GB; Menauer F; Blasenbreu-Vogt S; Löhrs U
Mod Pathol; 2000 Jan; 13(1):4-12. PubMed ID: 10658904
[TBL] [Abstract][Full Text] [Related]
17. Transitional cell tumors of the ovary: a comparative clinicopathologic, immunohistochemical, and molecular genetic analysis of Brenner tumors and transitional cell carcinomas.
Cuatrecasas M; Catasus L; Palacios J; Prat J
Am J Surg Pathol; 2009 Apr; 33(4):556-67. PubMed ID: 19033864
[TBL] [Abstract][Full Text] [Related]
18. Recurrence and progression in patients with non-muscle invasive bladder cancer: prognostic models including multicolor fluorescence in situ hybridization molecular grading.
Lodde M; Mian C; Mayr R; Comploj E; Trenti E; Melotti R; Campodonico F; Maffezzini M; Fritsche HM; Pycha A
Int J Urol; 2014 Oct; 21(10):968-72. PubMed ID: 24947145
[TBL] [Abstract][Full Text] [Related]
19. Chromosomal high-polysomies predict tumour progression in T1 transitional cell carcinoma of the bladder.
Ribal MJ; Alcaraz A; Mengual L; Carrio A; Lopez-Guillermo A; Mallofré C; Palou J; Gelabert A; Villavicencio H
Eur Urol; 2004 May; 45(5):593-9. PubMed ID: 15082201
[TBL] [Abstract][Full Text] [Related]
20. [Immunohistochemical study of p53 mutation and p16, p14 alterations encoded by INK4a-ARF in mucin-hypersecreting bile duct tumor].
Kim HJ; Kim MH; Song MH; Song DE; Yu E
Korean J Gastroenterol; 2005 Mar; 45(3):189-94. PubMed ID: 15778546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
